Table 3.
Characteristics of statin users reclassified according to lower adjusted D‐dimer level cut‐offs
| Patient | Sex (M/F) | Age | YEARS criteria (0‐3) | D‐dimer (ng/mL) | Use of antiplatelet drugs (yes/no) | Diagnostic failuresa (yes/no) | Death during follow‐up or lost to follow‐up (yes/no) |
|---|---|---|---|---|---|---|---|
| 1 | M | 79 | 1 | 442 | Yes | No | No |
| 2 | F | 70 | 1 | 450 | No | No | No |
| 3 | M | 76 | 1 | 468 | Yes | No | No |
| 4 | M | 62 | 1 | 470 | Yes | No | No |
| 5 | M | 72 | 1 | 480 | No | No | No |
| 6 | M | 62 | 1 | 492 | No | No | No |
| 7 | M | 67 | 0 | 860 | Yes | No | No |
| 8 | F | 54 | 0 | 890 | No | No | No |
| 9 | M | 77 | 0 | 910 | Yes | No | No |
| 10 | F | 74 | 0 | 913 | No | No | No |
| 11 | M | 85 | 0 | 930 | Yes | No | No |
| 12 | M | 75 | 0 | 990 | Yes | Nob | No |
Reclassification of statin users having no YEARS and D‐dimer ≥ 850 and <1000 ng/mL or statin users having YEARS ≥ 1 and D‐dimer ≥ 425 and <500 ng/mL.
a
Diagnostic failures are defined by venous thromboembolism during follow‐up, VTE‐related death during follow‐up or lost to follow‐up.
b
CTPA (computed‐tomography pulmonary‐angiography) conducted during follow‐up showing no pulmonary embolism.